Indefinite Delivery Contract 36E79720D0024

Award Date 7/1/20
Last Date to Order 5/27/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award, unrestricted IDC has a ceiling value of $4,792,297.44 and a period of performance through December 19, 2025. The contract covers the delivery of a variety of generic pharmaceutical products, including Dofetilide Capsules, to the VA, Department of...
This Indefinite Delivery Contract (IDC) was awarded by the VA National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract has a ceiling value of $10,379,933.80 and a period of performance from October 27, 2022 to October 26, 2025, with four one-year option periods. The contract is for the delivery of Sildenafil Citrate tablets in various strengths and package sizes to support the medication needs of the...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The $29,031,544.57 IDC covers the delivery of a wide range of branded and generic pharmaceutical products to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service through August 2029. Key items include medications such as ibuprofen, citalopram, albuterol,...
This federal contract IDV award was issued by the Department of Veterans Affairs (VA) National Acquisition Center to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The single-award, indefinite delivery contract has a ceiling value of $968,293.20 and a period of performance from May 28, 2025 to May 27, 2026, with four optional one-year extension periods. The contract is for the supply of Nadolol tablets in 20mg, 40mg,...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The single-award IDC, valued at up to $6,984,109.81, has an ultimate completion date of February 11, 2029. Under this contract, Exelan Pharmaceuticals will provide a variety of generic pharmaceutical products to the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award contract, valued at a ceiling of $12,802,166.10, is for the delivery of Ramipril capsules in various strengths and package sizes. The period of performance is from March 14, 2022, to March 13, 2023, with four one-year option periods. The...
This single-award Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The IDC has a ceiling value of $7,656,786.70 and a period of performance from June 3, 2025 to June 2, 2026, with four one-year option periods. The contract primarily consists of 6 line items for the delivery of Cyclobenzaprine HCL Tablets in various package sizes, including 30,...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a division of the Department of Veterans Affairs (VA), to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award, unrestricted contract has a ceiling value of $18,098,362.00 and a period of performance from March 2, 2021 to March 1, 2026. The contract is for the delivery of Pregabalin capsules, a generic pharmaceutical product, to the VA,...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award, unrestricted contract is valued at a ceiling of $52,330,802.25 and has a period of performance from June 15, 2020 to June 14, 2025, including a base year and four one-year option periods. The contract is for the supply of Diclofenac NA 1% Gel...
This federal contract IDV award to Exelan Pharmaceuticals Inc., a foreign-owned pharmaceutical company based in Florida, is a single-award Indefinite Delivery Contract (IDC) valued at up to $28,235,184.10. The contract was awarded by the Defense Logistics Agency, a defense agency, with no set-aside designations, allowing Exelan to compete openly. The contract encompasses the delivery of a wide range of generic pharmaceutical products to federal healthcare agencies such as the Department of...

This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract is for the procurement of Nadolol tablets in 20mg, 40mg, and 80mg dosages, with an estimated annual usage of 10,152 bottles, 8,817 bottles, and 2,349 bottles respectively.

The contract is a single-award, unrestricted procurement with a ceiling value of $915,921.00 and a period of performance from July 1, 2020 to June 30, 2021, with four one-year option periods. The purpose of this contract is to provide an uninterrupted source of supply for Nadolol tablets to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The products will be distributed through the VA's and Department of Defense's respective Pharmaceutical Prime Vendor Programs. Exelan Pharmaceuticals holds multiple IDCs and a Federal Supply Schedule contract for pharmaceuticals, demonstrating its capability to meet the complex medication needs of federal healthcare systems.

Generated 4/18/25, 2:12 PM